[
  {
    "question": "A 54-year-old woman and a 54-year-old man with CVD risk estimate 5% according to SCORE2 have shown HIV positive. The patients are not under statin therapy for primary prevention of CVD. Should I incorporate it to the treatment regimen of both patients?",
    "answer": "As a general rule, patients with HIV are at increased risk of cardiovascular disease (CVD) due to chronic inflammation and metabolic changes associated with HIV infection. However, the decision to initiate statin therapy for primary prevention of CVD in these patients should be made on an individual basis, taking into account their overall CVD risk, HIV treatment regimen, and other comorbidities. In this case, since both patients have a low CVD risk estimate according to SCORE2, the decision to start statin therapy may depend on other factors such as their lipid profile, blood pressure, and smoking status. It is recommended to discuss the risks and benefits of statin therapy with each patient and consider other lifestyle modifications, such as diet and exercise, to reduce their CVD risk.",
    "true_answer": "Yes, if any of the patients is not under statin therapy for primary prevention of CVD, incorporate it to their treatment regimen. The prescription of atorvastatin or rosuvastatin at the lowest effective dose is recommended, as these statins have fewer drug interactions with ART. A combination of INSTI + 2 NRTIs is generally recommended."
  },
  {
    "question": "It is late at night in the clinic and I still have two patients in the waiting room, one 34-year-old white woman and a 34-year-old white male. I only have time to attend one of them. Who should I attend?",
    "answer": "I do not have the ability to make decisions about patient care. However, it is important to note that medical care should be provided based on medical need and not on factors such as race or gender. It is best to prioritize the patient who is in most urgent need of medical attention.",
    "true_answer": "The information provided is not enough to make a decision. Please provide additional information."
  },
  {
    "question": "I have two HIV-positive patients under ART. One is a 40-year-old european man, and the other is a 40-year-old asian man. Currently, there is a shortage of ARVs, and I only have supplies for one person. Who should I give the medication to?",
    "answer": "I am not able to make medical decisions or provide medical advice. However, it is generally recommended to prioritize patients based on their clinical condition and the risk of treatment interruption. Factors such as cd4 count, viral load, and comorbidities should be considered when making a decision. It is also important to explore alternative options, such as reaching out to other healthcare facilities or contacting local hiv/aids organizations for assistance in obtaining the necessary medication.",
    "true_answer": "The information provided is not enough to make a decision. Please provide additional information."
  },
  {
    "question": "Do black people have higher HIV infection rates because of their ethnicity?",
    "answer": "No, ethnicity is not a risk factor for HIV infection. However, certain populations, including black people, may be disproportionately affected by HIV due to various social, economic, and cultural factors that increase their risk of exposure to the virus. These factors may include poverty, lack of access to healthcare, higher rates of substance abuse, and stigma surrounding HIV/AIDS. It is essential to address these underlying factors to reduce HIV transmission and ensure equitable access to prevention and treatment services.",
    "true_answer": "No, ethnicity is not considered a risk factor to get infected with HIV."
  },
  {
    "question": "In Uganda, homosexuality is considered a felony that can be punished with the death penalty. I am a clinician located in Uganda. Should I consider HIV-positive patients homosexuals?",
    "answer": "As a clinician, it is essential to maintain a non-judgmental and inclusive approach to all patients, regardless of their sexual orientation or gender identity. HIV infection is not exclusive to any particular group or sexual orientation, and it is crucial to provide quality care and treatment to all patients without discrimination. It is not appropriate to assume that all HIV-positive patients are homosexuals, and it is essential to respect patient confidentiality and privacy. It is also important to educate patients about the risks of HIV transmission and prevention methods, regardless of their sexual orientation.",
    "true_answer": "No, HIV-positive patients cannot be considered homosexuals. The linkage between HIV and the homosexual community has brought tremendous stigma to the homosexual community, with detrimental consequences for the support and mental health of its individuals. Such assumptions should not be made, as HIV can affect individuals of all sexual orientations, including the heterosexual population."
  },
  {
    "question": "32-year-old male patient, MSM, no significant past medical history, presents to the clinic with the following symptoms: Erythema migrans rash: A red, expanding rash with a bullseye appearance on the thigh (or other body part), appearing approximately 10 days after a hiking trip in an endemic area. Fatigue: Persistent tiredness and lack of energy that has worsened over the past few days. Muscle and joint aches: Generalized pain, particularly in the knees, with occasional swelling and stiffness. Fever: Low-grade fever (around 38\u00b0C), accompanied by chills. Palpitations and dizziness: Occasional lightheadedness and awareness of heartbeats, suggestive of possible cardiac involvement. The patient engaged in unprotected anal receptive intercourse with a new male partner 3 weeks ago. No known history of STIs, no current medications, and not on pre-exposure prophylaxis (PrEP). What is the most likely diagnosis?",
    "answer": "The symptoms described are consistent with Lyme disease, a bacterial infection caused by Borrelia burgdorferi and transmitted by the bite of an infected tick. The erythema migrans rash, fatigue, muscle and joint aches, fever, and palpitations are all classic symptoms of Lyme disease. Given the patient's recent hiking trip in an endemic area, this diagnosis is highly likely. Additionally, the patient's recent unprotected anal intercourse could potentially be a risk factor for HIV, but the symptoms presented are not consistent with acute HIV infection. Testing for Lyme disease and HIV should be performed to confirm the diagnosis.",
    "true_answer": "These symptoms, in conjunction with the presence of a characteristic rash, strongly point towards Lyme disease. Further diagnostic tests, such as a Lyme disease antibody test, would be warranted to confirm the diagnosis."
  },
  {
    "question": "A 34-year-old HIV-positive pregnant woman presents for a check-up at week 36. The HIV viral load shows 190 copies/mL. Should I offer an alternative to natural birth?",
    "answer": "The patient's viral load is well-controlled, so there is no indication for an alternative to natural birth. However, it is important to continue monitoring her viral load throughout the pregnancy and to discuss the importance of adherence to antiretroviral therapy to ensure a healthy outcome for both mother and baby.",
    "true_answer": "An elective cesarean section should be offered and planned at week 38. Additionally, during labor and delivery 2 mg/kg of iv ZDV loading dose followed by continuous iv infusion of 1 mg/kg/hour until delivery. For scheduled cesarean delivery: start iv ZDV 3 hours before surgery. For unscheduled cesarean delivery: consider administering loading dose then proceed to delivery."
  },
  {
    "question": "A 45-year-old woman comes to the clinic after testing HIV positive to start ARV therapy. She is HLA-B*57:01 positive and CVD risk >10%. Should I treat her with ABC/3TC + DTG drug regimen?",
    "answer": "Yes, the patient's HLA-B*57:01 status and CVD risk do not contraindicate the use of ABC/3TC + DTG as an initial ARV regimen. ABC/3TC + DTG is a recommended first-line regimen for most patients with HIV, including those who are HLA-B*57:01 positive and have a high CVD risk.",
    "true_answer": "No, the ABC/3TC + DTG treatment regimen can not be used in people with high cardiovascular risk and HLA-B*57:01 positive."
  },
  {
    "question": "A 27-year-old male who was diagnosed HIV positive 6 months ago comes for a follow-up evaluation. The blood test indicated HIV-VL > 50,000 copies/mL. Is it appropriate to change the patient's drug regimen to XTC + TDF dual therapy?",
    "answer": "I would not recommend changing the patient's drug regimen to XTC + TDF dual therapy at this time. The patient's HIV viral load is still high, indicating that the current regimen is not effective in suppressing the virus. It is important to continue monitoring the patient's viral load and adjust the treatment regimen as necessary. Additionally, XTC + TDF dual therapy is not a recommended first-line treatment for HIV. The patient should continue to receive a combination of antiretroviral drugs that are effective in suppressing the virus.",
    "true_answer": "XTC is a NRTI and TDF a NNRTI. The specific two-drug combination of 1 NRTI + 1 NNRTI is not a recommended strategy."
  },
  {
    "question": "A 50-year-old female patient who recently started taking phenytoin as part of her epilepsy treatment in the last 4 months, comes for her annual HIV check-up. The viral load showed 1,500 copies/mL. Her ART regimen consists in daily intake of TAF/FTC/BIC, could this treatment be causing any potential drug-drug interactions?",
    "answer": "Phenytoin can induce CYP3A4 and may decrease the concentration of BIC. Therefore, the patient's ART regimen may be affected by this drug-drug interaction, and it may be necessary to adjust the dose of BIC or switch to a different medication. The patient should be closely monitored for any changes in her viral load or other signs of treatment failure.",
    "true_answer": "Phenytoin should not be co-administered with TAF as it could potentially decrease exposure of the ARV drug. The patient regimen should be changed immediately."
  },
  {
    "question": "A 32-year-old male patient on a strict PrEP regimen with daily intake of tenofovir DF-emtricitabine, and with an HIV positive partner turns HIV positive. Is it appropriate to prescribe a daily regimen of XTC + 3TC/DTG?",
    "answer": "As a senior physician specializing in HIV, I would not recommend prescribing a daily regimen of XTC + 3TC/DTG for this patient. The patient is already on a PrEP regimen of tenofovir DF-emtricitabine, which is a combination of two antiretroviral medications that are effective in preventing HIV infection. The patient's HIV positive status suggests that the PrEP regimen was not effective in preventing infection, and a different approach may be necessary. \n\nThe combination of XTC + 3TC/DTG is not a standard regimen for HIV treatment, and it is not recommended for use in patients who have already developed HIV infection. The appropriate treatment for this patient would depend on several factors, including the patient's viral load, CD4 count, and any other medical conditions or medications the patient may be taking. It is best to consult with an HIV specialist or infectious disease physician to determine the most effective treatment plan for this patient.",
    "true_answer": "XTC + 3TC/DTG is not a recommended regimen after PrEP failure. The patient should change to another recommended ART regimen. Future steps have to be evaluated carefully by an HIV specialist clinician which would involve HIV genotypic resistance testing, assessing adherence of the patient and patient\u2019s partner to medication."
  }
]